New imaging tracer could spot tumors more clearly

NCT ID NCT07258836

Recruiting now Diagnosis Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This early-stage study tests a new injection called [18F]LY4214835 to see if it is safe and how it spreads in the body. It includes healthy volunteers and people with cancer. The goal is to improve how doctors see tumors using imaging scans.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY NEOPLASMS

Contacts and locations

Locations

BAMF Health Inc.
NOT_YET_RECRUITING

Grand Rapids, Michigan, 49503, United States
Boston Medical Center
NOT_YET_RECRUITING

Boston, Massachusetts, 02118, United States
Ichor Research
RECRUITING

Syracuse, New York, 13210, United States
Invicro
COMPLETED

New Haven, Connecticut, 06510, United States
Massachusetts General Hospital (MGH)
NOT_YET_RECRUITING

Charlestown, Massachusetts, 02129, United States
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.